Identifying Therapeutic Factors in an 8-Week (30 Hour) Mindfulness-Based Stress Reduction (MBSR) Program

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01599143

Acronym

mbsr

Enrollment

135

Registered

2012-05-15

Start date

2009-01-31

Completion date

2012-04-30

Last updated

2012-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Diabetes, Hypertension

Keywords

Mindfulness, Pain Disorder (Chronic physical or mental health complaints:, Fibromyalgia; Migraines; Back Pain; etc), Anxiety Disorder/Anxiety State

Brief summary

Since it's introduction in 1979 at the University of Massachusetts Medical Center by Dr. Jon Kabat-Zinn, Mindfulness-Based Stress Reduction (MBSR) has become a respected adjunct to conventional treatment for patients suffering from many diverse chronic ailments. Three decades of research have documented it's benefits, but few papers have focused on identifying which particular aspect of MBSR directly correlates with it's degree of therapeutic efficacy. This study will use 7 well validated questionnaires to compare participants responses prior to, and following completion of an eight-week MBSR program at the North York General Hospital, as well as follow-up results at 1 month and 1 year post completion of the MBSR group.

Detailed description

As above

Interventions

BEHAVIORALTeaching Mindfulness-based Stress Reduction strategies

Daily meditation, Hatha yoga,and cognitive restructuring

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* over 18 years old * suffer from a chronic health problem * referred by their physician

Exclusion criteria

* acute illness (physical or psychiatric) * suicidal * problem use of alcohol or other substances * inability to do one hour of daily homework * inability to attend all 8 sessions

Design outcomes

Primary

Measure	Time frame	Description
PSS-10	baseline, 8 weeks and follow-ups at 1 month and 1 year	Patients' Stress Scores on the PSS-10 are used to assess self-reported perceptions of stress at baseline, at 8 weeks when the intervention ends, and again at one month and one year follow-up (to see if any change is sustained).

Secondary

Measure	Time frame	Description
Toronto Mindfulness Scale (TMS)	Baseline, 8 weeks and follow up at 1 month and 1 year	Measure of patients' self-reported capacity for detached curiosity / decentering (aspects of mindfulness), prior to intervention, at the end of the intervention (8 weeks), and at short-term (one month)and long-term (one year) follow-up.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026